| Q34471468 | 5-HT7 receptor activation promotes an increase in TrkB receptor expression and phosphorylation |
| Q30402212 | A flow cytometric approach to study the mechanism of gene delivery to cells by gemini-lipid nanoparticles: an implication for cell membrane nanoporation |
| Q26865163 | A holistic approach to targeting disease with polymeric nanoparticles |
| Q92084212 | Amphiphilic Acrylic Nanoparticles Containing the Poloxamer Star Bayfit® 10WF15 as Ophthalmic Drug Carriers |
| Q47834991 | An intraocular drug delivery system using targeted nanocarriers attenuates retinal ganglion cell degeneration |
| Q38703014 | Interactions between DNA and Gemini surfactant: impact on gene therapy: part I. |
| Q38829320 | Nanocarrier mediated retinal drug delivery: overcoming ocular barriers to treat posterior eye diseases. |
| Q36396201 | Nanoparticle-motivated gene delivery for ophthalmic application |
| Q34953629 | Nanosponge-Mediated Drug Delivery Lowers Intraocular Pressure |
| Q38573732 | Neuroprotective therapies in glaucoma: I. Neurotrophic factor delivery |
| Q89920527 | Niosome-Based Approach for In Situ Gene Delivery to Retina and Brain Cortex as Immune-Privileged Tissues |
| Q36425890 | Non-viral therapeutic approaches to ocular diseases: An overview and future directions |
| Q39269584 | Recent Advances in Nanomaterials for Gene Delivery-A Review |
| Q26740095 | The intricacies of neurotrophic factor therapy for retinal ganglion cell rescue in glaucoma: a case for gene therapy |